Published in J Rheumatol on December 01, 2002
Development and implementation of a pharmacist-managed clinical pharmacogenetics service. Am J Health Syst Pharm (2011) 1.85
Implementation of TPMT testing. Br J Clin Pharmacol (2014) 0.96
Posttraumatic stress symptoms and health-related quality of life: a two year follow up study of injury treated at the emergency department. BMC Psychiatry (2012) 0.96
Pharmacogenetics: implications for therapy in rheumatic diseases. Nat Rev Rheumatol (2011) 0.90
Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapy. Eur J Clin Pharmacol (2010) 0.86
Economic Evaluations of Pharmacogenetic and Pharmacogenomic Screening Tests: A Systematic Review. Second Update of the Literature. PLoS One (2016) 0.79
Thiopurine methyltransferase genotyping in Palestinian childhood acute lymphoblastic leukemia patients. BMC Hematol (2013) 0.77
Thiopurine S-methyltransferase (TPMT) activity is better determined by biochemical assay versus genotyping in the Jewish population. Dig Dis Sci (2014) 0.77
Alterations of chemotherapeutic pharmacokinetic profiles by drug-drug interactions. Expert Opin Drug Metab Toxicol (2009) 0.76
Two cases of thiopurine methyltransferase (TPMT) deficiency--a lucky save and a near miss with azathioprine. Br J Clin Pharmacol (2006) 0.76
Clinician adoption of genetic testing for drug metabolizing enzymes: is patient safety the low-hanging fruit of personalized medicine? AMIA Annu Symp Proc (2009) 0.75
Immunosuppression in clinical practice: approaches to individualized therapy. J Neurol (2008) 0.75
Cost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in Germany. Adv Ther (2016) 0.75
Thiopurine S-methyltransferase polymorphisms in acute lymphoblastic leukemia, inflammatory bowel disease and autoimmune disorders: influence on treatment response. Pharmgenomics Pers Med (2017) 0.75
Azathioprine prescribing in neurology. J Neurol (2008) 0.75
Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet? Pharmacogenomics J (2017) 0.75
The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health (2009) 9.79
Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum (2008) 4.20
Therapies for active rheumatoid arthritis after methotrexate failure. N Engl J Med (2013) 3.51
Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis. Ann Intern Med (2009) 3.03
Gaps in care for rheumatoid arthritis: a population study. Arthritis Rheum (2005) 2.20
Long-term (10-year) mortality of younger previously healthy patients with severe sepsis/septic shock is worse than that of patients with nonseptic critical illness and of the general population. Crit Care Med (2014) 2.19
Impact of supply-side policies for control of illicit drugs in the face of the AIDS and overdose epidemics: investigation of a massive heroin seizure. CMAJ (2003) 2.18
Safety and efficiency of emergency department assessment of chest discomfort. CMAJ (2004) 2.09
A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med (2005) 2.07
Randomized, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis. Arthritis Rheum (2004) 1.87
Intensive care unit admission has minimal impact on long-term mortality. Crit Care Med (2002) 1.73
Cardiovascular risk factor screening in systemic lupus erythematosus. J Rheumatol (2003) 1.64
Productivity loss due to presenteeism among patients with arthritis: estimates from 4 instruments. J Rheumatol (2010) 1.64
Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus? Arthritis Rheum (2008) 1.63
Defining dosing pattern characteristics of successful tapers following methadone maintenance treatment: results from a population-based retrospective cohort study. Addiction (2012) 1.62
Effect of sociodemographic factors on surgical consultations and hip or knee replacements among patients with osteoarthritis in British Columbia, Canada. J Rheumatol (2010) 1.57
The relationship between osteoarthritis and cardiovascular disease in a population health survey: a cross-sectional study. BMJ Open (2013) 1.55
Managing arthritis and employment: making arthritis-related work changes as a means of adaptation. Arthritis Rheum (2004) 1.54
Workplace, psychosocial factors, and depressive symptoms among working people with arthritis: a longitudinal study. J Rheumatol (2006) 1.54
Measuring and valuing productivity loss due to poor health: A critical review. Soc Sci Med (2010) 1.52
Evaluating health-related quality-of-life studies in paediatric populations: some conceptual, methodological and developmental considerations and recent applications. Pharmacoeconomics (2005) 1.50
Reliability of the knee examination in osteoarthritis: effect of standardization. Arthritis Rheum (2004) 1.46
Trends in methadone maintenance treatment participation, retention, and compliance to dosing guidelines in British Columbia, Canada: 1996-2006. J Subst Abuse Treat (2010) 1.44
When patients have to pay a share of drug costs: effects on frequency of physician visits, hospital admissions and filling of prescriptions. CMAJ (2005) 1.42
Cost-effectiveness: cholinesterase inhibitors and memantine in vascular dementia. Can J Neurol Sci (2009) 1.41
Cost-effectiveness of diacetylmorphine versus methadone for chronic opioid dependence refractory to treatment. CMAJ (2012) 1.37
Association of biomarkers with pre-radiographically defined and radiographically defined knee osteoarthritis in a population-based study. Arthritis Rheum (2009) 1.35
Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis. Arthritis Rheum (2008) 1.33
Predictors of back pain in a general population cohort. Spine (Phila Pa 1976) (2004) 1.28
A comparison of four indirect methods of assessing utility values in rheumatoid arthritis. Med Care (2004) 1.27
Descriptive epidemiology of osteoarthritis in British Columbia, Canada. J Rheumatol (2006) 1.27
HIV-positive injection drug users who leave the hospital against medical advice: the mitigating role of methadone and social support. J Acquir Immune Defic Syndr (2004) 1.27
Validity of the work productivity and activity impairment questionnaire--general health version in patients with rheumatoid arthritis. Arthritis Res Ther (2010) 1.26
Proportional hazards frailty models for recurrent methadone maintenance treatment. Am J Epidemiol (2009) 1.26
The validity and responsiveness of generic utility measures in rheumatoid arthritis: a review. J Rheumatol (2008) 1.20
Posterior reversible encephalopathy syndrome--an underrecognized manifestation of systemic lupus erythematosus. J Rheumatol (2006) 1.19
The indirect costs of arthritis resulting from unemployment, reduced performance, and occupational changes while at work. Med Care (2006) 1.17
Approval process and access to prescription drugs in Canada. Arthritis Rheum (2006) 1.15
Identification of modifiable work-related factors that influence the risk of work disability in rheumatoid arthritis. Arthritis Rheum (2004) 1.11
Risk of cardiovascular disease in patients with osteoarthritis: a prospective longitudinal study. Arthritis Care Res (Hoboken) (2013) 1.10
Infliximab treatment of rheumatoid arthritis and Crohn's disease. Ann Pharmacother (2003) 1.10
Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study. Rheumatology (Oxford) (2012) 1.10
Trends in physician-diagnosed osteoarthritis incidence in an administrative database in British Columbia, Canada, 1996-1997 through 2003-2004. Arthritis Rheum (2008) 1.10
Health related quality of life trajectories of patients in opioid substitution treatment. Drug Alcohol Depend (2011) 1.09
Are indirect utility measures reliable and responsive in rheumatoid arthritis patients? Qual Life Res (2005) 1.08
Quality of nonpharmacological care in the community for people with knee and hip osteoarthritis. J Rheumatol (2011) 1.06
Minimal clinically important difference for 7 measures of fatigue in patients with systemic lupus erythematosus. J Rheumatol (2008) 1.05
Arthritis-related work transitions: a prospective analysis of reported productivity losses, work changes, and leaving the labor force. Arthritis Rheum (2008) 1.05
Reliability, validity, and responsiveness of five at-work productivity measures in patients with rheumatoid arthritis or osteoarthritis. Arthritis Care Res (Hoboken) (2010) 1.02
Patient education and self-management of musculoskeletal diseases. Best Pract Res Clin Rheumatol (2008) 1.02
Glucosamine sulfate and cartilage type II collagen degradation in patients with knee osteoarthritis: randomized discontinuation trial results employing biomarkers. J Rheumatol (2005) 1.01
A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study. Arthritis Rheum (2005) 1.01
Cost-effectiveness of hip protectors in the prevention of osteoporosis related hip fractures in elderly nursing home residents. J Rheumatol (2004) 1.00
The impact of cost sharing of prescription drug expenditures on health care utilization by the elderly: own- and cross-price elasticities. Health Policy (2006) 0.99
Reliability of the hip examination in osteoarthritis: effect of standardization. Arthritis Rheum (2008) 0.99
Predictors of early hospital readmission in HIV-infected patients with pneumonia. J Gen Intern Med (2003) 0.97
The economic burden of rheumatoid arthritis: beyond health care costs. Clin Rheumatol (2011) 0.97
Association of clinical findings with pre-radiographic and radiographic knee osteoarthritis in a population-based study. Arthritis Care Res (Hoboken) (2010) 0.96
A randomized double blind, placebo controlled trial of topical Tripterygium wilfordii in rheumatoid arthritis: reanalysis using logistic regression analysis. J Rheumatol (2003) 0.96
After patients are diagnosed with knee osteoarthritis, what do they do? Arthritis Care Res (Hoboken) (2010) 0.96
Risk of cerebrovascular disease associated with the use of glucocorticoids in patients with incident rheumatoid arthritis: a population-based study. Ann Rheum Dis (2011) 0.95
Determinants of the cost of health services used by veterans with HIV. Med Care (2011) 0.95
Impact of welfare cheque issue days on a service for those intoxicated in public. Harm Reduct J (2007) 0.95
Determination of the minimal clinically important difference for seven fatigue measures in rheumatoid arthritis. J Clin Epidemiol (2008) 0.95
The validity of generic and condition-specific preference-based instruments: the ability to discriminate asthma control status. Qual Life Res (2008) 0.94
Assessment of health-related quality of life in arthritis: conceptualization and development of five item banks using item response theory. Health Qual Life Outcomes (2006) 0.94
An overview of economic evaluations for drugs used in rheumatoid arthritis : focus on tumour necrosis factor-alpha antagonists. Drugs (2005) 0.93
Measuring worker productivity: frameworks and measures. J Rheumatol (2009) 0.93
Reconcilable differences: a cross-sectional study of the relationship between socioeconomic status and the magnitude of short-acting beta-agonist use in asthma. Chest (2004) 0.93
Racial differences in social network experience and perceptions of benefit of arthritis treatments among New York City Medicare beneficiaries with self-reported hip and knee pain. Arthritis Rheum (2002) 0.93
Short-term influence of adalimumab on work productivity outcomes in patients with rheumatoid arthritis. J Rheumatol (2008) 0.93
The systemic lupus erythematosus Tri-Nation study: cumulative indirect costs. Arthritis Rheum (2007) 0.92
The effect of motivational status on treatment outcome in the North American Opiate Medication Initiative (NAOMI) study. Drug Alcohol Depend (2010) 0.92
Pharmacist-initiated intervention trial in osteoarthritis: a multidisciplinary intervention for knee osteoarthritis. Arthritis Care Res (Hoboken) (2012) 0.92
Development of a composite questionnaire, the valuation of lost productivity, to value productivity losses: application in rheumatoid arthritis. Value Health (2011) 0.92
Best practices for cardiovascular disease prevention in rheumatoid arthritis: a systematic review of guideline recommendations and quality indicators. Arthritis Care Res (Hoboken) (2015) 0.92
Measuring time input loss among patients with rheumatoid arthritis: validity and reliability of the Valuation of Lost Productivity questionnaire. J Occup Environ Med (2011) 0.91
Health-related quality of life in a randomized trial of antiretroviral therapy for advanced HIV disease. J Acquir Immune Defic Syndr (2009) 0.91
Do visual analogue scale (VAS) derived standard gamble (SG) utilities agree with Health Utilities Index utilities? A comparison of patient and community preferences for health status in rheumatoid arthritis patients. Health Qual Life Outcomes (2006) 0.90
The effect of disease site (knee, hip, hand, foot, lower back or neck) on employment reduction due to osteoarthritis. PLoS One (2010) 0.90
Pelvic bone asymmetry in 323 study participants receiving abdominal CT scans. Spine (Phila Pa 1976) (2003) 0.90
Counterbalancing patient demands with evidence: results from a pan-Canadian randomized clinical trial of brief supportive-expressive group psychotherapy for women with systemic lupus erythematosus. Ann Behav Med (2002) 0.90
The quality of eight health status measures were compared for chronic opioid dependence. J Clin Epidemiol (2010) 0.89
Reliability of hip examination tests for femoroacetabular impingement. Arthritis Care Res (Hoboken) (2013) 0.88
Medical withdrawal management in Vancouver: service description and evaluation. Addict Behav (2006) 0.87
Patterns of inhaled asthma medication use: a 3-year longitudinal analysis of prescription claims data from British Columbia, Canada. Chest (2002) 0.87
Highly active antiretroviral therapy and hospital readmission: comparison of a matched cohort. BMC Infect Dis (2006) 0.86
Do spouses know how much fatigue, pain, and physical limitation their partners with rheumatoid arthritis experience? Implications for social support. Arthritis Care Res (Hoboken) (2011) 0.85
Measuring the impact of arthritis on worker productivity: perspectives, methodologic issues, and contextual factors. J Rheumatol (2011) 0.84
High levels of opioid analgesic co-prescription among methadone maintenance treatment clients in British Columbia, Canada: results from a population-level retrospective cohort study. Am J Addict (2014) 0.84
Improving osteoarthritis detection in the community: pharmacist identification of new, diagnostically confirmed osteoarthritis. Arthritis Rheum (2007) 0.84
The Work Instability Scale for Rheumatoid Arthritis (RA-WIS): Does it work in osteoarthritis? Qual Life Res (2010) 0.83